Home›Companies›Healthcare›Ascellus

Ascellus Health, Inc.

Behavioral health care for injured workers and workers' compensation claims.

Updated Nov 10, 2026·Latest SEC filing Mar 31, 2026·Suggest an edit

About Ascellus

Ascellus is a private company based in Miami, Florida. It has reported $20,743,349 raised in 12 offerings on Form D since June 2015. Its chief executive is Joseph Holtschlag.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 24, 2025May 9, 2025amended Mar 31, 2026$2,059,027of $2.7M target9$228KEquityRule 506(b)Form D/A ↗1 earlier filing
Sep 6, 2024Sep 13, 2024$806,256of $1.0M target2$403KSecurities on exercise, Convertible DebtRule 506(b)Form D ↗
Feb 27, 2023Nov 9, 2023$4,600,000of $7.6M target3$1.5MOptions, Securities on exercise, Convertible DebtRule 506(b)Form D ↗
Oct 6, 2022Oct 18, 2022$100,000of $1.6M target3$33,333Securities on exercise, Convertible DebtRule 506(b)Form D ↗
Apr 28, 2022May 6, 2022$500,000of $1.5M target4$125KSecurities on exercise, Convertible DebtRule 506(b)Form D ↗
Nov 2, 2021Nov 17, 2021$1,328,066of $3.5M target2$664KSecurities on exercise, Convertible DebtRule 506(b)Form D ↗
Jul 9, 2020Jul 22, 2020$8,000,000fully sold7$1.1MEquityRule 506(b)Form D ↗
Jul 15, 2019Jul 30, 2019$1,500,000of $3.0M target2$750KEquity, OptionsRule 506(b)Form D ↗
Mar 15, 2019Mar 29, 2019$300,000of $500K target11$27,273Debt, OptionsRule 506(b)Form D ↗
Not yetFeb 22, 2018$0of $850K target0—Revenue Sharing AgreementRule 506(b)Form D ↗
May 27, 2016Jun 2, 2016$1,000,000of $1.9M target1$1.0MEquity, OptionsRule 506(b)Form D ↗
May 29, 2015Jun 4, 2015$550,000fully sold9$61,111Debt, Options, Securities on exerciseRule 506(b)Form D ↗
Total, 12 offerings$20,743,349

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Ascellus's Form D filed Mar 31, 2026.

SC
JW
Jeff Williams
Executive officer
MT
Martha Temple
Director
Also a director at Cortica.
LD
KW
Kevin Wang
Director
Also a director at RELAI.
JH
Joseph Holtschlag
Chief Executive Officer and director

Earlier filings also listed W. Uehlein (director, last listed Sep 2024), Vincent Fabiani (director, last listed Nov 2023), Loraine Daugherty (chief executive officer and director, last listed Oct 2022), W. Uehlien (director, last listed May 2022), Steve Chevalier (director, last listed Jul 2020), Michael Coupland (executive officer and director, last listed Jul 2020), E. Griswold (director, last listed Jun 2016) and Carol Valentic (chief executive officer, last listed Jun 2016).

Sources

  1. SECAscellus Health, Inc. Form D, filed May 9, 2025
  2. SECAscellus Health, Inc. filing history
  3. InvestorAscellus announces Martha Temple's appointment
  4. PressAscellus announces Martha Temple as chairperson